Archives of Medical Research
Volume 40, Issue 8 , Pages 687-692 , November 2009

Identification of Seasonal Vaccine Hemagglutinin Subtype 1 (H1) Epitopes in Mexican Isolates of the New Influenza A (H1N1) 2009 Virus

Received 10 November 2009 ,Accepted 20 November 2009.

References 

  1. Swine influenza A (H1N1) infection in two children—southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:400–402
  2. Outbreak of swine-origin influenza A (H1N1) virus infection−Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:467–470
  3. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26(suppl 4):D49–D53
  4. Fouchier RA, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol. 2005;79:2814–2822
  5. Webster RG, Bean WJ, Gorman OT, et al. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152–179
  6. Parvin JD, Moscona A, Pan WT, et al. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol. 1986;59:377–383
  7. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med. 2000;51:407–421
  8. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615
  9. Miller MA, Vidou C, Simonsen C, et al. Mortality and morbidity burden associated with A/H1N1pdm influenza virus: who is likely to be infected, experience of clinical symptoms, or die from the H1N1pdm 2009 pandemic virus?. Version 2. PLoS Currents: Influenza. 2009 Aug 26;[revised 2009 Sep 2];RRN1013
  10. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–689
  11. Chang LY, Shih SR, Shao PL, et al. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc. 2009;108:526–532
  12. Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361:674–679
  13. Schild GC, Newman RW, McGregor IA, et al. The use of transportable single-radial-diffusion immunoplates in seroepidemiological studies of influenza in the Gambia. The occurrence and persistence of antibody to influenza A/Hong Kong/68 (H3N2) virus in selected inhabitants of two rural villages. Bull WHO. 1977;55:3–13
  14. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58:521–524
  15. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;
  16. De Groot AS, Ardito M, McClaine EM, et al. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008–2009 conventional influenza vaccine. Vaccine. 2009;27:5740–5747
  17. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ. 2009;339:b3928
  18. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol. 2004;59:1–15
  19. Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. J Clin Invest. 2008;118:3273–3275
  20. Treanor J. Weathering the influenza vaccine crisis. N Engl J Med. 2004;351:2037–2040
  21. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA. 1988;85:2444–2448
  22. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673–4680
  23. Chen MW, Cheng TJ, Huang Y, et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci USA. 2008;105:13538–13543
  24. Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol. 2009;16:265–273
  25. Gog JR. The impact of evolutionary constraints on influenza dynamics. Vaccine. 2008;26(suppl 3):C15–C24
  26. Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci USA. 2007;104:246–251
  27. Prabhu N, Prabakaran M, Ho HT, et al. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol. 2009;83:2553–2562
  28. Recommended composition of influenza virus vaccines for use in the 2004–2005 influenza season. Week Epidemiol Rec. 2004;79:88–92
  29. Recommended composition of influenza virus vaccines for use in the 2005–2006 influenza season. Week Epidemiol Rec. 2005;80:71–75
  30. Recommended composition of influenza virus vaccines for use in the 2006–2007 influenza season. Week Epidemiol Rec. 2006;81:82–86
  31. Recommended composition of influenza virus vaccines for use in the 2007–2008 influenza season. Week Epidemiol Rec. 2007;82:69–74
  32. Recommended composition of influenza virus vaccines for use in the 2008–2009 influenza season. Week Epidemiol Rec. 2008;83:81–87
  33. Recommended composition of influenza virus vaccines for use in the 2009–2010 influenza season (northern hemisphere winter). Week Epidemiol Rec. 2009;84:65–72
  34. www.who.in/csr/resources/publications/swineflu/ivr153_20090608_en.pdf

PII: S0188-4409(09)00228-8

doi: 10.1016/j.arcmed.2009.12.002

Archives of Medical Research
Volume 40, Issue 8 , Pages 687-692 , November 2009

Article Tools